The Impact of the Phase III Pipeline: Future Projections and Market Disruptions
Mar 1, 2006
480 Pages - Pub ID: KLI1187684
Ask a question about this report >
Email a colleague >
Printer format >
Order by fax >
Abstract Table of Contents Search Inside Report Buy By the Section Related Reports

To purchase a section of this report, click the checkbox next to the sections and click the "add sections to cart" button. Learn more >


 Chapter OneExecutive Summary (pp. 26 - 35)  $500.00
 Chapter Two Introduction (pp. 35 - 59)  $490.00
 Chapter Three Cardiovascular Drugs Phase III Development Analysis (pp. 59 - 103)  $1,150.00
 Chapter Four Neuropsychotherapeutic Drugs Phase III Development Analysis (pp. 103 - 201)  $1,400.00
 Chapter Five Infectious Disease Phase III Development Analysis (pp. 201 - 253)  $1,050.00
 Chapter Six Cancer Drugs Phase III Development Analysis (pp. 253 - 341)  $1,400.00
 Chapter Seven Other Drugs Phase III Development Analysis (pp. 341 - 409)  $895.00
 Chapter Eight Market Summary (pp. 409 - 419)  $1,200.00
 Chapter Nine Company Profiles (pp. 419 - 467)  $675.00
 Appendix Company Directory (pp. 467 - 486)  $157.00
800.298.5603
Int'l: +1.240.747.3096
Questions?
Contact a research specialist >
Most Popular Research
Anesthesia Drugs: Worldwide Markets
Outsourcing in Drug Discovery: The Contract Research (CRO) Market, 3rd Edition
Vaccines: The World Market
Vaccines 2008: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry
The Worldwide Market for Dialysis Equipment, Supplies, and Services, 2nd Edition
Prescription Dermatological Drugs: Worldwide Market, 6th Edition
Privacy Policy    |    Terms and Conditions    |    Site Map    |    Return Policy    |    Press    |    Help FAQs
Copyright © 2007 Kalorama Information. All Rights Reserved.
A division of Market Research Group, LLC
Trust-e Logo
Contact Us: 800.298.5603 (U.S.)
or +1.240.747.3096 (Int'l)
Hours: 7:00 a.m. to 7:00 p.m. EST Monday through Friday